Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis

BACKGROUND: Erectile dysfunction(ED) is common in patients with chronic liver disease(CLD). Although it significantly worsens the quality of life, caregivers and researchers often neglect it. AIM: Evaluating the prevalence of ED in patients with CLD, associated factors, and response to therapy with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Exp Hepatol
Asıl Yazarlar: Thakur, Jitender, Rathi, Sahaj, Grover, Sandeep, Chopra, Madhu, Agrawal, Swastik, Taneja, Sunil, Duseja, Ajay, Bhansali, Anil, Chawla, Yogesh K., Dhiman, Radha K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637079/
https://ncbi.nlm.nih.gov/pubmed/31360023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.07.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller